Developing new antibiotics requires a different approach than most other medicines. Thank you, Senator Marshall, for raising the need for innovative solutions that strengthen the antibiotic pipeline and ensure lifesaving treatments are available when patients need them. #PASTEURAct

🚨 Already halfway full! Advance your career with IDSA’s Rising Leaders program, an online-only program for early career ID/HIV professionals. Participants will receive career coaching valued at $1,925. Learn more and apply by August 21: https://bit.ly/4fuXuzd

OFID is seeking research on infectious diseases in rural areas in the U.S., incl. fungal, bacterial, viral and parasitic infections, investments in ID workforce development and strategies for addressing vaccine hesitancy. Submit a proposal by Sept. 13: https://bit.ly/4xjOhzl

A strong infectious diseases workforce is essential to protecting patients, stresses IDSA member Vera Luther, MD, FIDSA. #ValueofID Thank you, Senator Cortez Mastro (@cortezmasto.senate.gov), for raising this critical issue during yesterday's Finance Committee hearing.

Antimicrobial resistance threatens far more than the treatment of infections. It puts routine surgeries, cancer care, organ transplants and neonatal care at risk, stressed IDSA member Vera Luther, MD, FIDSA, during today’s Finance Committee hearing. #PASTEURAct

Innovation is essential to staying ahead of antimicrobial resistance. Thank you, Senator Young, for highlighting the need to strengthen the antibiotic pipeline and ensure physicians have the tools they need to save lives. #PASTEURAct

Antimicrobial resistance is a growing public health threat that demands action. Thank you @hassan.senate.gov for your leadership and for recognizing the importance of investing in new antibiotics so physicians can continue providing lifesaving care. #PASTEURAct

In CID, authors present the antiviral effect, pharmacokinetics, safety, and tolerability of oral VH-499 from a proof-of-concept phase 2a trial in people with HIV-1. https://bit.ly/45GefRM

Antiviral Effect, Safety, and Tolerability of Oral VH4011499 (VH-499), a New HIV-1 Capsid Inhibitor: Proof-of-Concept Trial

AbstractBackground. Innovative HIV-1 therapies, especially those with infrequent dosing, are a promising approach to advance progress toward the UNAIDS goa

bit.ly

Clinical Infectious Diseases is now on Roon, a physician-only platform for medical discussion and collaboration: https://www.roon.com/doctors/p/cid Follow CID on Roon to engage with the latest ID research, share insights, and connect with colleagues across the medical community.

Are you an aspiring ID professional, or an experienced leader ready to give back? iDMentorship365 connects early-career health professionals with seasoned mentors in ID for a year of meaningful mentorship. Learn more and apply to be a mentee or a mentor by Aug. 14: https://bit.ly/4ldntKF

The future of infectious diseases starts with today's trainees. Discover sessions tailored for medical students, residents and fellows at #IDWeek2026. Browse IDWeek's entire Trainee track in the Interactive Program: https://bit.ly/4wHhhRW

🚨 DEADLINE APPROACHING: The IDSA MedEd Community of Practice's ID Abstract Guidance Program is returning to #IDWeek2026! The program connects IDWeek presenters with experienced mentors who provide feedback on oral/poster presentations. Sign up by Aug. 3: https://bit.ly/4f7Alkp

ID physician Anthony Fauci, MD, FIDSA has led with courage, scientific integrity and an unwavering commitment to improving public health. These qualities inspired IDSA to establish the Anthony Fauci Courage in Leadership Award. We thank him for his service to patients, science & the ID community.

New #IDSAGuidelines out now! IDSA has released updated evidence-informed guidance on the management of antimicrobial-resistant infections: www.idsociety.org/practice-gui...

Congratulations to IDSA Past President and former IDSA Foundation Chair, William G. Powderly, MD, FIDSA, on being named the inaugural Larry J. Shapiro Distinguished Professor in Interdisciplinary Health Sciences at Washington University School of Medicine. https://bit.ly/4fH7pAh

William G. Powderly, MD – Larry J. Shapiro Distinguished Professor in Interdisciplinary Health Sciences - John T. Milliken Department of Medicine

It is my pleasure to announce that Dr. William G. Powderly will be named the Larry J. Shapiro Distinguished Professor in Interdisciplinary Health Sciences on August 1st. Dr. Powderly is currently the Dr. J. William Campbell Professor of Medicine and Dir...

bit.ly

It's #IDBugBowl Pop Quiz Thursday! 🧠💡 Which chronic soft tissue disease is characterized by the presence of "grains" that are aggregates of microbes in a "cement-like matrix" produced by the pathogens and are often heavily melanized? Comment your guess! Answer reveal tomorrow.

“Don't you guys just give antibiotics?” 💊 Not quite.   Hear from IDSA CEO Jeanne Marrazzo, MD, MPH, FIDSA, about what infectious diseases professionals really do.   TikTok saw it first 👀: tiktok.com/@idsainfo

IDSA CEO Jeanne Marrazzo, MD, MPH, FIDSA, served as guest editor for a new supplement in the Journal of the International AIDS Society, exploring the latest in STI research, vaccine development and strategies to improve vaccine uptake. Read the supplement: onlinelibrary.wiley.com/toc/17582652...

<em>Journal of the International AIDS Society</em> | IAS HIV Research Journal | Wiley Online Library

Click on the title to browse this issue

onlinelibrary.wiley.com

In OFID, authors evaluated #mpox severity over time in a limited number of mpox cases following primary intradermal MVA-BN vaccination. https://bit.ly/4x5KZj0

Mpox Disease Severity Reduced in Intradermally MVA-BN Vaccinated Compared to Unvaccinated Patients in Sweden: A Retrospective 2024–2025 Observational Case-series

bit.ly

Knowledge is key to eliminating viral hepatitis. This #WorldHepatitisDay, explore IDSA resources to strengthen hepatitis diagnosis, treatment and patient care with HCV guidance, HBV recommendations, CME/MOC modules and more. Learn more: https://bit.ly/4dqInEj

One of the most surprising summertime infections isn't spread by mosquitoes. ID doctor Thomas Moore, MD, FIDSA, of the University of Kansas, explains "lawn mower #tularemia" and how people can become infected during routine outdoor activities. Watch the full briefing: https://bit.ly/4yHqZ8e

New #LetsTalkID! Buddy Creech, MD, MPH, FPIDS, speaks with Todd Wolynn, MD, MMM, executive director of the Trusted Messenger Program, about how clinicians can navigate difficult conversations & guide patients toward evidence-based decisions. Transcript: https://bit.ly/4g1d5W3

LAST CALL: Stay up-to-date on the COVID-19 vaccine landscape. Join our Bartlett webinar this Wed. July 29 at 1pm ET to explore vaccine platforms, patient experience, co-administration opportunities and immunological insights with expert faculty. Register: https://bit.ly/4eU6Ofk

ICYMI: In honor of #WorldHepatitisDay, IDSA is co-sponsoring a free webinar this Tuesday, July 28 at 7pm ET with API, AASLD and ALEH. Register: bit.ly/3T8X08H

IDSA@idsainfo.bsky.social · 4w ago

In honor of #WorldHepatitisDay, IDSA is co-sponsoring a free webinar on July 28 at 7pm ET with API, AASLD and ALEH. Hear the latest updates on hepatitis C and hepatitis B, plus a roundtable discussion on the elimination of viral hepatitis in Latin America. Register: https://bit.ly/3T8X08H

What's next for COVID-19? Discover sessions exploring emerging evidence, clinical challenges and new developments in the COVID-19 track at #IDWeek2026. Browse IDWeek's entire COVID-19 track in the Interactive Program: https://bit.ly/4bVBbjp

The IDSA MedEd Community of Practice's ID Abstract Guidance Program is returning to #IDWeek2026! The program connects IDWeek presenters with experienced mentors who provide feedback on oral and poster presentations. Sign up as a mentor by Aug. 3: https://bit.ly/4f7Alkp

The CEO facts nobody had on their bingo card. 🎂🐕🇮🇹 TikTok saw it first 👀: tiktok.com/@idsainfo

On IDSA’s & HIVMA’s Science Speaks blog: A study in The Lancet compared benzylpenicillin with anti-staphylococcal penicillins for the treatment of PSSA bacteremia in adults. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA. https://bit.ly/4wVx5A0

Making a SNAP decision to prescribe penicillin over anti-staphylococcal penicillins for PSSA bacteremia

A study compared benzylpenicillin with anti-staphylococcal penicillins for the treatment of PSSA bacteraemia in adults.

bit.ly

The Senate HELP Committee advanced the #EMPOWERforHealth Act, including reauthorization of the Bio-Preparedness Workforce Pilot Program. Thank you to @reed.senate.gov & Sen. Lisa Murkowski for leading the bill, & @baldwin.senate.gov & Sen. Susan Collins for leading the Bio Pilot reauthorization. ⬇️

Early career ID/HIV health care professionals: 🔥Ignite your journey to leadership with Rising Leaders. Topics include: ✅Coaching & mentoring ✅Leadership fundamentals ✅Communication & conflict ✅Problem solving & project management Apply by Aug. 21: https://bit.ly/3RkAngX